CE/CME Statement

Intended Audience

This activity was developed for dermatologists and other clinicians who treat patients with moderate to severe psoriasis.

Learning Objectives

At the conclusion of this activity, participants should be better able to:

  • Summarize the latest research developments in the management of moderate to severe psoriasis
  • Incorporate evidence-based research into clinical practice


Steven R. Feldman, MD, PhD
Professor of Dermatology, Pathology and Public Health Sciences
Department of Dermatology
Wake Forest University School of Medicine
Winston-Salem, North Carolina



Alan Menter, MD
Chair, Division of Dermatology
Director, Baylor Psoriasis Research and Dermatology Residency Program
Baylor University Medical Center at Dallas
Principal Faculty, Texas A&M University Health Science Center College of Medicine
Clinical Professor, University of Texas Southwestern Medical School Dallas, Dallas, Texas


Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Steven R. Feldman, MD, PhD
                     Research Support                AbbVie, Anacor, Galderma, Janssen, National Biological, Novartis

                     Consultant                          AbbVie,  Amgen, Celgene, Janssen, LEO Pharma, Lilly, Merck, Mylan, Novartis, Pfizer, Qurient

                     Speakers Bureau                Celgene, Janssen, Novartis

                     Significant Shareholder       Causa, DrScore

Alan Menter, MD
                    Research Support                AbbVie, Allergan, Amgen, Boehringer Ingelheim, Celgene,  Lilly, Genentech, LEO Pharma, Merck, Novartis, Pfizer, Symbio/Maruho, Syntrix, Wyeth

                    Consultant                          AbbVie, Allergan, Amgen, Convoy Therapeutics, Janssen, Lilly, LEO Pharma, Novartis, Pfizer, Syntrix, Vitae, Wyeth, XenoPort

                    Speakers Bureau                AbbVie, Amgen, Janssen, LEO Pharma, Wyeth

                    Advisory Board                  AbbVie, Allergan, Amgen, Boehringer Ingelheim, Lilly, Genentech, Janssesn, LEO Pharma, Pfizer                

The faculty for this activity has disclosed that there will be no discussion about the use of products for non-FDA approved indications.

Additional content planners
The following have no significant relationship to disclose.

Josh Paul (medical writer)

Annenberg Center for Health Sciences
John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.


This activity is supported by an independent educational grant from Celgene Corporation and Novartis Pharmaceuticals Corporation.

This activity is supported by an educational donation provided by Amgen.

This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications in your practice, and completing the assessment component. 

The estimated time to complete the activity is 2.5 hours.

Our Policy on Privacy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

Contact Information

39000 Bob Hope Drive 
Dinah Shore Building
Rancho Mirage, CA 92270
Phone    760-773-4500
Fax    760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday